Updated on 2021/03/16

写真a

 
FUKAMI Tatsuya
 
Organization
Nagoya University Hospital Quality and Patient Safety Lecturer of hospital
Title
Lecturer of hospital

Degree 1

  1. 博士(医学) ( 2009.3   福岡大学 ) 

Research Interests 5

  1. Patient Safety

  2. 周産期医学 分子生物学

  3. Quality Improvement

  4. Simulation Training

  5. perinatal medicine molecular biology

Research Areas 4

  1. Life Science / Obstetrics and gynecology

  2. Life Science / Medical management and medical sociology

  3. Life Science / Obstetrics and gynecology

  4. Life Science / Medical management and medical sociology

Research History 15

  1. Nagoya University   Nagoya University Hospital Quality and Patient Safety   Lecturer of hospital

    2020.1

  2. Nagoya University Hospital   Lecturer of hospital

    2018.10

      More details

    Country:Japan

  3. Nagoya University Hospital   Lecturer of hospital

    2018.10 - 2019.12

  4. Nagoya University   Designated lecturer

    2018.1 - 2018.9

      More details

    Country:Japan

  5. Nagoya University   Designated lecturer

    2018.1 - 2018.9

  6. Nagoya University   Graduate School of Medicine   Designated lecturer

    2018.1 - 2018.9

  7. ASO Iizuka Hospital

    2013.4 - 2017.12

      More details

    Country:Japan

  8. ASO Iizuka Hospital

    2013.4 - 2017.12

  9. Fukuoka University University Hospital, Fukuoka University Hospital   Assistant Professor

    2012.4 - 2013.3

      More details

    Country:Japan

  10. 福岡大学病院・地域周産期医学講座(寄附講座)   助手

    2012.1 - 2012.3

      More details

    Country:Japan

  11. カリフォルニア大学ロサンゼルス校・博士研究員

    2009.9 - 2011.12

      More details

    Country:Japan

  12. 福岡大学病院   産婦人科   助手

    2009.4 - 2009.8

      More details

    Country:Japan

  13. 福岡徳洲会病院・産婦人科

    2004.4 - 2005.3

      More details

    Country:Japan

  14. 麻生飯塚病院   産婦人科

    2000.4 - 2002.3

      More details

    Country:Japan

  15. 福岡大学病院   産婦人科

    1999.5 - 2000.3

      More details

    Country:Japan

▼display all

Education 2

  1. Fukuoka University   Graduate School, Division of Medicine

    2005.4 - 2009.3

      More details

    Country: Japan

  2. Fukuoka University   Faculty of Medicine

    1993.4 - 1999.3

Professional Memberships 10

  1. 医療の質・安全学会

  2. 日本産婦人科学会

  3. 日本周産期学会

  4. THE JAPAN SOCIETY OF ULTRASONICS IN MEDICINE

  5. 日本臨床遺伝学会

  6. JAPAN SOCIETY FOR HEALTH CARE MANAGEMENT

  7. THE JAPAN SOCIETY OF ULTRASONICS IN MEDICINE

  8. 日本産婦人科学会

  9. 日本周産期学会

  10. 医療の質・安全学会

▼display all

Committee Memberships 1

  1. 福岡産婦人科医会   J-CIMELS運営委員  

    2016   

      More details

    Committee type:その他

Awards 8

  1. 飯塚病院学術奨励賞受賞 英文原著等領域 努力賞 優秀賞

    2018  

    深見 達弥

  2. 飯塚病院学術奨励賞受賞 英文原著等領域 努力賞 優秀賞

    2018  

    深見 達弥

  3. 第3回ALSO-Japan学術集会 優秀演題賞

    2017  

    深見 達弥

  4. 第3回ALSO-Japan学術集会 優秀演題賞

    2017  

    深見 達弥

  5. 第2回ALSO-Japan学術集会 最優秀演題賞

    2016  

    深見 達弥

  6. 飯塚病院学術奨励賞受賞 英文原著等領域 優秀賞

    2015  

    深見 達弥

  7. International session award

    2013  

    FUKAMI Tatsuya

  8. 第12回福岡大学医学会賞 銀賞

    2010  

    深見 達弥

▼display all

 

Papers 10

  1. Significance of incident reports by medical doctors for organizational transparency and driving forces for patient safety. Reviewed International journal

    Tatsuya Fukami, Masakazu Uemura, Yoshimasa Nagao

    Patient safety in surgery   Vol. 14 ( 1 ) page: 13 - 13   2020

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Background: Incident reporting is an effective strategy used to enhance patient safety and quality improvement in healthcare. An incident is an event that could eventually result in harm to a patient. The aim of this study is to re-evaluate the importance of reporting by medical doctors to improve quality in healthcare and patient safety. Methods: We conducted a retrospective analysis of the reported incidents registered in our institutional database from April 1st 2015 to March 31st 2019, classified according to eight variables proposed by the National University Hospital Council of Japan, to determine the type of incidents and their potential harm to patients. Results: Registered reports totalled 43,775, approximately 8% of which arise annually from medical doctors in clinical departments. Incidents with higher impact on patients have significantly increased the rate of reporting by medical doctors. The most frequent types of report overall concerned medication incidents, followed by infusion lines, drainage-tube devices, cure, examination, and treatment outside the operating room. The most frequent reports by medical doctors involved operation-related incidents, followed by cure, examination, treatment outside the operation room, and medications. Conclusion: Reporting by medical doctors reflects the organizational transparency and the driving forces behind patient safety and quality improvement in healthcare. Efforts toward seamless improvement in patient safety and quality at our hospital continue apace.

    DOI: 10.1186/s13037-020-00240-y

    Web of Science

    Scopus

    PubMed

  2. Enhanced hospital-wide communication and interaction by team training to improve patient safety. Reviewed

    Tatsuya Fukami, Masakazu Uemura, Mineko Terai, Yoshimasa Nagao

    Nagoya journal of medical science   Vol. 82 ( 4 ) page: 697 - 701   2020.11

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    Communication errors are the most important cause of adverse events in healthcare. The current study aimed to improve hospital-wide employee teamwork and reduce adverse medical events for patients arising from miscommunication. In our hospital, when patient safety incidents and accidents occur, staff from various occupations submit incident reports to the Department of Patient Safety via an electronic reporting system; over 11,000 cases are reported each year. We surveyed the incident reports submitted in our institution from 2016 to 2018. All incidents related to miscommunication were identified, and relevant information was collected from the original electronic incident reports. Incident severity classification is commonly divided into near-miss or adverse events. We extracted only the required incident information items for this study, and processed information concerning individuals (e.g., reporters and target patients) anonymously. This study was approved by the Institutional Review Board of the study hospital. The authors declare no conflicts of interest associated with this study. Team training for all employees reduced adverse events for patients. The coefficient of determination (R squared value) was -0.32. This suggests our approach may be slightly but significantly effective for developing the fundamental strengths of the medical team. Quality improvement is continuous, and seamless efforts to improve the effectiveness of medical teams at our hospital will continue.

    DOI: 10.18999/nagjms.82.4.697

    Web of Science

    Scopus

    PubMed

  3. Doctors-in-training support strategy from incident report point of view. Reviewed International journal

    Tatsuya Fukami, Masakazu Uemura, Yoshimasa Nagao

    Annals of medicine and surgery   Vol. 56   page: 139 - 141   2020.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.amsu.2020.06.032

    Web of Science

    Scopus

    PubMed

  4. Intervention efficacy for eliminating patient misidentification using step-by-step problem-solving procedures to improve patient safety. Reviewed

    Tatsuya Fukami, Masakazu Uemura, Mineko Terai, Tomomi Umemura, Mika Maeda, Mayumi Ichikawa, Naoko Sawai, Fumimasa Kitano, Yoshimasa Nagao

    Nagoya journal of medical science   Vol. 82 ( 2 ) page: 315 - 321   2020.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    This study aimed to evaluate the efficacy of interventions to reduce patient misidentification incidents classified as level 2 and over (adverse events occurred for patients) with the step-by-step problem-solving method. All incidents related to patient misidentification were selected, and relevant information was collected from the original electronic incident reports. We then conducted an eight-step problem-solving process with the aim of reducing patient misclassification and improving patient safety. Step 1: the number of misidentification-related incident reports and the percentage of these reports in the total incident reports increased each year. Step 2: the most frequent misidentification type was sample collection tubes, followed by drug administration and hospital meals. Step 3: we set a target of an 20% decrease in patient misidentification cases classified as level 2 or over compared with the previous year, and established this as a hospital priority. Step 4: we found that discrepancies in patient identification procedures were the most important causes of misidentification. Step 5: we standardized the patient identification process to achieve an 10% reduction in misidentification. Step 6: we disseminated instructional videos to all staff members. Step 7: we confirmed there was an 18% reduction in level 2 and over patient misidentification compared with the previous year. Step 8: we intend to make additional effort to decrease misidentification of patients by a further 10%. Level 2 and over patient misidentification can be reduced by a patient identification policy using a step-by-step problem-solving procedure. This study aimed to evaluate the efficacy of interventions to reduce patient misidentification incidents with step-by-step problem-solving method. Continued seamless efforts to eliminate patient misidentification are mandatory for this activity.

    DOI: 10.18999/nagjms.82.2.315

    Web of Science

    Scopus

    PubMed

  5. Incidence and risk factors for postpartum hemorrhage among transvaginal deliveries at a tertiary perinatal medical facility in Japan. Reviewed International journal

    Tatsuya Fukami, Hidenobu Koga, Maki Goto, Miho Ando, Sakiko Matsuoka, Atsushi Tohyama, Hiroko Yamamoto, Sumie Nakamura, Takahiro Koyanagi, Yoko To, Haruhiko Kondo, Fuyuki Eguchi, Hiroshi Tsujioka

    PloS one   Vol. 14 ( 1 ) page: e0208873   2019

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Postpartum hemorrhage (PPH) remains a leading cause of maternal death worldwide, and it is important to understand the relative contributions of different risk factors. We assessed the incidence of these among cases of transvaginal delivery. Between June 2013 and July 2016, a prospective cohort study was conducted at a tertiary perinatal medical facility in Japan. Women were administered a questionnaire to ascertain risk factors for PPH, defined as a blood loss of 1,000 ml or more assessed using a calibrated under-buttocks drape and collection vessel at childbirth. We analyzed 1,068 transvaginal deliveries of singleton pregnancies. The incidence of PPH was 8.7%, and of severe PPH (1,500 ml blood loss or more) was 2.1%. Risk factors for postpartum hemorrhage among the deliveries were: fetal macrosomia (over 4000 g); pregnancy-induced hypertension; pregnancy generated by assisted reproductive technology; severe vaginal or perineal lacerations; and weight gain over 15 kg during pregnancy. Such high weight gain significantly increased the incidence of PPH compared with women showing less than 10 kg weight gain during pregnancy. Monitoring these identified risk factors could enable extra vigilance during labor, and preparedness for managing PPH in all women giving birth.

    DOI: 10.1371/journal.pone.0208873

    PubMed

  6. Follow-up study of symptomatic submucous fibroids after hysteroscopic myomectomy Reviewed

    H. Tsujioka, S. Matsuoka, S. Sorano, H. Yamamoto, S. Nakamura, A. Tohyama, T. Fukami, M. Goto, R. Matsuoka, F. Eguchi

    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY   Vol. 44 ( 1 ) page: 61 - 64   2017

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:I R O G CANADA, INC  

    Purpose of investigation: This study aimed to estimate the effectiveness of hysteroscopic myomectomy for symptomatic submucous uterine fibroids and to identify prognostic factors for persistent or recurrent symptoms. Materials and Methods: A total of 237 patients who underwent hysteroscopic myomectomy were divided into three groups according to the classification of the European Society for Gynaecological Endoscopy: Type 0 (n=116), Type I (n=97), and Type II (n=24). Medical records and videotape records of all patients were retrospectively reviewed. Results: Improvement of symptoms was achieved in 100% of Types 0 and I, and 66.7% of Type II. The five-year cumulative symptom-free rates after hysteroscopic myomectomy were 96.7%+/- 1.9%, 87.8%+/- 6.7%, and 44.5%+/- 12.7% in Types 0, I, and II, respectively. The mean symptom-free periods were 46.2 +/- 2.6, 47.7 +/- 2.7, and 24.7 +/- 6.3 months in Types 0, I, and II, respectively. Logistic regression analysis showed that co-existence of other myomas and Type II were independent prognostic factors for recurrence of symptoms. Conclusion: Type I fibroids are a good indication for hysteroscopic myomectomy. In Type II, some patients feel that their symptoms improve, but this curative effect could be temporary.

    DOI: 10.12891/ceog3254.2017

    Web of Science

  7. The relation between causes and onset time of polyhydramnios Reviewed

    T. Fukami, M. Goto, S. Matsuoka, S. Nishijima-Sorano, A. Tohyama, H. Yamamoto, S. Nakamura, R. Matsuoka, H. Tsujioka, F. Eguchi

    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY   Vol. 44 ( 1 ) page: 113 - 115   2017

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:I R O G CANADA, INC  

    The aim of this analysis was to investigate the onset time and significance of maximum volume of polyhydraminios and whether the latter was associated with causes. This was a retrospective cohort study between 2012 and 2014. A total number of 68 singleton pregnancies were analyzed. Gestational age at onset of polyhydramnios was 30.0 +/- 2.8 (25-36) weeks in maternal factor, 30.0 +/- 3.5 (25-37) weeks in fetal factor, and 32.3 +/- 2.0 (27-37) weeks in idiopathic factor. Median of maximum amniotic fluid index (AFI) was significantly late onset in idiopathic factor. Diabetes, gestational or pre-existing, was present in all of women (ten cases) in maternal factor. Higher AFT was found to be associated with an increased frequency of prenatally detected congenital anomalies. Abnormal fetal karyotype noted in 18/45 (40%) cases of polyhydramnios. Polyhydramnios diagnosed on ultrasound requires further maternal and fetal diagnostic tests.

    DOI: 10.12891/ceog3335.2017

    Web of Science

  8. Seminoma leading to detection of testicular feminization syndrome: a case report Reviewed

    S. Nakamura, H. Tsujioka, T. Fukami, M. Goto, R. Matsuoka, F. Eguchi

    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY   Vol. 38 ( 1 ) page: 153 - 156   2017

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:I R O G CANADA, INC  

    The authors here report a 54-year-old (gravida 0, para 0), who claimed to have had her menarche at age 13 and menopause at 52 years. Two months prior to presentation, the subject first noticed a hard but elastic fist-sized mass in the left inguinal region that gradually grew, causing pressure-related pain. Although the external genitalia appeared female, the vagina was short and blind-ending, and no uterus or ovaries were identified on transvaginal ultrasound. Chromosome banding results (G-band method) showed 46XY. Laparoscopy revealed no traces of a vestigial uterus or ovaries; thus, based on the appearance of the external genitalia, a diagnosis of testicular feminization syndrome was made. Pathological testing of the palpable mass led to a diagnosis of seminoma with Leydig cell hyperplasia. Thus, in this case, the development of a seminoma in an undescended testis led to the detection of testicular feminization syndrome.

    DOI: 10.12892/ejgo3435.2017

    Web of Science

  9. Retroperitoneal leiomyosarcoma: a case report Reviewed

    T. Matsuoka, H. Tsujioka, S. Matsuoka, S. Sorano, A. Toyama, H. Mori, H. Yamamoto, S. Nakamura, T. Fukami, M. Goto, R. Matsuoka, F. Eguchi

    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY   Vol. 38 ( 1 ) page: 150 - 152   2017

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:I R O G CANADA, INC  

    Retroperitoneal leiomyosarcoma is a relatively rare and aggressive tumor. Because of its rarity, it is difficult to arrive at a definite diagnosis preoperatively and to design an effective strategy. Here the authors report a case of peritoneal leiomyosarcoma in which diagnosis was difficult because the clinical course resembled that of ovarian cancer. A 77-year-old woman diagnosed with ovarian cancer underwent laparotomy. The excised tumor contained a necrotic polypoid mass that histologically displayed the features of leiomyosarcoma. The patient received adjuvant chemotherapy with a combination of gemcitabine and docetaxel but died two months after surgery owing to the aggressive behavior of the tumor. Because the preoperative diagnosis in this case was ovarian cancer, arriving at a treatment strategy assuming peritoneal leiomyosarcoma was difficult. If complete surgical resection of tumor is not performed, as in the present case, the prognosis can be extremely poor.

    DOI: 10.12892/ejgo3413.2017

    Web of Science

  10. Histologic chorioamnionitis prevalence in patients with premature rupture membranes Reviewed

    T. Fukami, M. Goto, S. Matsuoka, S. Nishijima-Sorano, A. Tohyama, H. Yamamoto, S. Nakamura, R. Matsuoka, H. Tsujioka, F. Eguchi

    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY   Vol. 44 ( 2 ) page: 236 - 238   2017

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:I R O G CANADA, INC  

    This was a retrospective cohort study between 2002 and 2011. A total number of 150 singleton pregnancies with preterm premature rupture of membranes (PROM) (before 34 weeks) were analyzed. Histological chorioamnionitis (Blanc grade III) was significantly increased over three days from onset of premature rupture of membranes. The positive relationship was strengthened (odds ratios, 3.5; 95% confidence intervals, 1.5-5.2) over three days from onset of preterm PROM. PROM is a risk factor important for histological chorioamnionitis. To avoid neonatal infection, early termination is recommended in preterm PROM patients.

    DOI: 10.12891/ceog3373.2017

    Web of Science

▼display all

Books 2

  1. Fusion therapy of cellular and humoral immunity for cancer using antibodies or their genes against carcinoembryonic antigen. In: Recent Research Development in Immunology

    深見 達弥( Role: Joint author)

    Research Signpost  2008 

  2. Fusion therapy of cellular and humoral immunity for cancer using antibodies or their genes against carcinoembryonic antigen. In: Recent Research Development in Immunology

    FUKAMI Tatsuya( Role: Joint author)

    Research Signpost  2008 

MISC 47

  1. Malignant lymphoma of the uterine cervix presumptively diagnosed by Pap smear: A case report. Reviewed

    Koyanagi T, Kondo H, Toyama A, Ando M, Imaoka S, Inamura M, Yamamoto H, Nakamura S, To Y, Fukami T, Goto M, Tsujioka H, Eguchi F

    Oncology letters   Vol. 15 ( 5 ) page: 6678-6680   2018.5

     More details

  2. Choosing the uterine preservation surgery for placental polyp determined by blood flow evaluation: A retrospective cohort study. Reviewed

    Sorano S, Fukami T, Goto M, Imaoka S, Ando M, To Y, Nakamura S, Yamamoto H, Eguchi F, Tsujioka H

    Annals of medicine and surgery (2012)   Vol. 23   page: 13-16   2017.11

  3. BK-UM in patients with recurrent ovarian cancer or peritoneal cancer: a first-in-human phase-I study. Reviewed

    Miyamoto S, Yotsumoto F, Ueda T, Fukami T, Sanui A, Miyata K, Nam SO, Fukagawa S, Katsuta T, Maehara M, Kondo H, Miyahara D, Shirota K, Yoshizato T, Kuroki M, Nishikawa H, Saku K, Tsuboi Y, Ishitsuka K, Takamatsu Y, Tamura K, Matsunaga A, Hachisuga T, Nishino S, Odawara T, Maeda K, Manabe S, Ishikawa T, Okuno Y, Ohishi M, Hikita T, Mizushima H, Iwamoto R, Mekada E

    BMC cancer   Vol. 17 ( 1 ) page: 89   2017.1

  4. Histologic chorioamnionitis prevalence in patients with premature rupture membranes. Reviewed

    Fukami T, Goto M, Matsuoka S, Sorano SN, Tohyama A, Yamamoto H, Nakamura S, Matsuoka R, Tsujioka H, Eguchi F.

    Clinical and Experimental Obstetrics and Gynecology   Vol. 45   page: 236-238   2017

  5. The relation between causes and onset timing polyhydramnios. Reviewed

    Fukami T, Goto M, Matsuoka S, Sorano SN, Tohyama A, Yamamoto H, Nakamura S, Matsuoka R, Tsujioka H, Eguchi F.

    Clinical and Experimental Obstetrics and Gynecology   Vol. 44   page: 113-115   2017

  6. Follow-up study of symptomatic submucous fibroids after hysteroscopic myomectomy. Reviewed

    Tsujioka H, Matsuoka S, Sorano S, Yamamoto H, Nakamura S, Toyama A, Fukami T, Goto M, Matsuoka R, Eguchi F.

    Clnical and Experimental Obstetrics and Gynecology   Vol. 44   page: 61-64   2017

  7. Seminoma leading to detection of testicular feminization syndrome: A case report. Reviewed

    Nakamura S, Tsujioka H, Fukami T, Goto M, Matsuoka R, Eguchi F

    European Journal of Obstetrics and Gynecology   Vol. 38   page: 153-156   2017

  8. Retroperitoneal leiomyosarcoma: A case report. Reviewed

    Matsuoka T, Tsujioka H, Matsuoka S, Sorano S, Tohyama A, Mori H, Yamamoto H, Nakamura S, Fukami T, Goto M, Matsuoka R, Eguchi F

    European Journal of Obstetrics and Gynecology   Vol. 38   page: 150-153   2017

  9. Monochorionic-diamniotic discordant growth in a twin pregnancy with one fetus affected by Ebstein's anomaly of tricuspid leaflets. Reviewed

    Fukami T, Goto M, Matsuoka S, Sorano S, Tohyama A, Yamamoto H, Nakamura S, Matsuoka R, Tsujioka H, Eguchi F

    Clinical case reports   Vol. 4 ( 7 ) page: 682-686   2016.7

     More details

  10. Chorioamnionitis caused by Staphylococcus aureus with intact membranes in a term pregnancy: A case of maternal and fetal septic shock. Reviewed

    Sorano S, Goto M, Matsuoka S, Tohyama A, Yamamoto H, Nakamura S, Fukami T, Matsuoka R, Tsujioka H, Eguchi F

    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy   Vol. 22 ( 4 ) page: 261-264   2016.4

  11. Positron Emission Tomography Findings in Atypical Polypoid Adenomyoma. Reviewed

    Fukami T, Yoshikai T, Tsujioka H, Tohyama A, Sorano S, Matsuoka S, Yamamoto H, Nakamura S, Goto M, Matsuoka R, Oya M, Torii Y, Eguchi F

    Rare tumors   Vol. 8 ( 1 ) page: 6129   2016.3

     More details

  12. Preferential development of neuropeptide Y/GABA circuit in hypothalamic arcuate nucleus in postnatal rats. Reviewed

    Sun X, Fukami T, Li T, Desai M, Ross MG

    Brain research   Vol. 1635   page: 27-40   2016.3

  13. 産婦人科の地域医療構想:九州編:家庭医と産婦人科医の協働と九州の非大学基幹施設連携 Reviewed

    深見達弥、安藤美穂、今岡咲子、遠山篤史、山本広子、中村寿美得、藤庸子、後藤麻木、近藤晴彦、辻岡寛、江口冬樹

    九州連合産科婦人科学会雑誌   Vol. 67   page: 36   2016

  14. Solitary transverse colon metastasis: A rare case of uterine cervical cancer recurrence. Reviewed

    Fukami T, Tsujioka H, Matsuoka S, Sorano S, Tohyama A, Yamamoto H, Nakamura S, Goto M, Matsuoka R, Eguchi F

    Eastern Journal of Medicine   Vol. 21   page: 98-100   2016

  15. Rupture risk factors of fallopian tubal pregnancy. Reviewed

    Fukami T, Tsujioka H, Matsuoka S, Sorano S, Tohyama A, Yamamoto H, Nakamura S, Goto M, Matsuoka R, Eguchi F

    Clinical and Experimental Obstetrics and Gynecology   Vol. 43   page: 800-802   2016

  16. Adhesional omental hernia: A case report. Reviewed

    Fukami T, Tsujioka H, Goto M, Matsuoka R, Nakamura S, Miyagawa M, Mori H, Eguchi F

    Annals of medicine and surgery (2012)   Vol. 3 ( 4 ) page: 134-136   2014.12

  17. Mechanism of programmed obesity: altered central insulin sensitivity in growth-restricted juvenile female rats. Reviewed

    Fukami T, Sun X, Li T, Yamada M, Desai M, Ross MG

    Journal of developmental origins of health and disease   Vol. 4 ( 3 ) page: 239-248   2013.6

  18. Clinical significance of amphiregulin and epidermal growth factor in colostrum. Reviewed

    Nojiri T, Yoshizato T, Fukami T, Obama H, Yagi H, Yotsumoto F, Miyamoto S

    Archives of gynecology and obstetrics   Vol. 286 ( 3 ) page: 643-647   2012.9

  19. Mechanism of programmed obesity in IUGR offspring: Paradoxically enhanced appetite stimulation in fed and fasting states.

    Fukami T, Sun X, Li T, Desai M, Ross MG.

    Reproductive sciences     2012

     More details

  20. Assessment of HB-EGF levels in peritoneal fluid and serum of ovarian cancer patients using ELISA. Reviewed

    Hikita S, Yotsumoto F, Fukami T, Horiuchi S, Sanui A, Miyata K, Nam SO, Tsujioka H, Ueda T, Shirota K, Yoshizato T, Maeda K, Ishikawa T, Okuno Y, Kuroki M, Mekada E, Miyamoto S

    Anticancer research   Vol. 31 ( 7 ) page: 2553-2559   2011.7

     More details

  21. A possible clinical adaptation of CRM197 in combination with conventional chemotherapeutic agents for ovarian cancer.

    Tsujioka H, Fukami T, Yotsumoto F, Ueda T, Hikita S, Takahashi Y, Kondo H, Kuroki M, Miyamoto S.

    Anticancer research   Vol. 31   page: 2461-2466   2011

  22. Amphiregulin を標的とした膵癌治療

    四元 房典, 深見 達弥, 八木 裕史, 船越 顕博, 吉里 俊幸, 黒木 政秀, 宮本 新吾

    日本分子腫瘍マーカー研究会誌   Vol. 26   page: 51-52   2011

  23. Antitumor effects of CRM197, a specific inhibitor of HB-EGF, in T-cell acute lymphoblastic leukemia.

    Kunami N, Yotsumoto F, Ishitsuka K, Fukami T, Odawara T, Manabe S, Ishikawa T, Tamura K, Kuroki M, Miyamoto S.

    Anticancer research   Vol. 31   page: 2483-2488   2011

  24. HB-EGF inhibition in combination with various anticancer agents enhances its antitumor effects in gastric cancer.

    Sanui A, Yotsumoto Y, Tsujioka H, Fukami T, Horiuchi S, Shirota K, Yoshizato T, Kuroki M, Miyamoto S.

    Anticancer research   Vol. 30   page: 3143-3149   2010

  25. 卵巣癌におけるHB-EGF特異的抑制剤CRM197とPaclitaxelによる相乗的抗腫瘍効果

    讃井絢子, 八木裕史, 四元房典, 深見達弥, 辻岡 寛, 堀内新司, 黒木政秀, 宮本新吾

    日本分子腫瘍マーカー研究会誌   Vol. 25   page: 21-22   2010

  26. 胎児期の栄養状態がメタボリック症候群発症をプログラムする機序の基礎的検討

    深見達弥

    中山科学振興財団活動報告書2009     page: 94-100   2010

  27. Amphiregulin regulates the activation of ERK and Akt through EGFR and HER3 signals involved in the progression of pancreatic cancer. Reviewed

    Yotsumoto F, Fukami T, Yagi H, Funakoshi A, Yoshizato T, Kuroki M, Miyamoto S.

    Cancer Science   Vol. 101 ( 11 ) page: 2351-2360   2010

  28. Longitudinal changes in canal length at 16-35 weeks in normal twin pregnancies and twin pregnancies with preterm labor and delivery.

    Yoshizato T, Inoue Y, Fukami T, Sanui A, Miyamoto S, Kawarabayashi T.

    Journal of Obstetrics and Gynaecology Research   Vol. 36 ( 4 ) page: 733-738   2010

  29. Potential for molecularly targeted therapy against epidermal growth factor receptor ligands. Reviewed

    Miyamoto S, Fukami T, Yagi H, Kuroki M, Yotsumoto F

    Anticancer research   Vol. 29 ( 3 ) page: 823-830   2009.3

     More details

  30. Efficacy of ligand-based targeting for the EGF system in cancer.

    Yotsumoto F, Sanui A, Fukami T, Shirota K, Horiuchi S, Tsujioka H, Yoshizato T, Kuroki M, Miyamoto S.

    Anticancer research   Vol. 29   page: 4879-4885   2009

  31. Amphiregulin regulates the production of human chorionic gonadotropin in trophoblasts.

    Fukami T, Yoshizato T, Miyamoto S, Yagi H, Yotsumoto F, Nabeshima K, Hachisuga T, Kuroki M, Kawarabayashi T.

    Life Sciences   Vol. 84 ( 23-24 ) page: 796-804   2009

  32. Potential for molecularly targeted therapy against epidermal growth factor receptor ligands.

    Miyamoto S, Fukami T, Yagi H, Kuroki M, Yotsumoto F.

    Anticancer research   Vol. 28   page: 823-830   2008

  33. Obstetrical factors for death and brain injury among extremely-low-birth weight infants.

    Fukami T, Yoshizato T, Mori T, Yukitake K, Miyake Y, Kawarabayashi T.

    Journal of Perinatal Medicine   Vol. 35   page: 543-549   2007

     More details

  34. HB-EGFを標的とした癌標的治療

    四元房典,八木裕史,深見達弥,目加田英輔,宮本新吾

    細胞   Vol. 39   page: 292-295   2007

  35. Possible applications of antibodies or their genes in cancer therapy.

    Kuroki M, Huang J, Shibaguchi H, Tanaka T, Zhao J, Luo N, Hachimine K, Kinugasa T, Maekawa S, Enatsu S, Hamanaka W, Fukami T, Kuroki M.

    Anticancer research   Vol. 26   page: 4019-4026   2006

  36. Sonographic findings of transvaginal color Doppler ultrasound in ectopic pregnancy.

    Fukami T, Emoto M, Tamura R, Kawarabayashi T

    Journal of Medical Ultrasonics   Vol. 33 ( 1 ) page: 37-42   2006

  37. Pregnancy complicated by multiple pituitary hormone deficiencies.

    Fukami T, Makino Y, Kawarabayashi T

    Journal of Obstetrics and Gynaecology Research   Vol. 32 ( 2 ) page: 252-256   2006

  38. 血液凝固第XIII因子欠乏症合併妊娠周産期管理の経験

    深見達弥

    産婦人科治療   Vol. 90   page: 1059-1062   2005

  39. 変性子宮筋腫により敗血症性ショックをきたした1症例

    深見達弥,安達正武, 窪田孝明

    福岡大学医学紀要   Vol. 32   page: 109-112   2005

  40. 緊急頸管縫縮術に関する検討

    長谷川ゆり,深見達弥,安達正武,窪田孝明

    日本産婦人科学会九州連合地方部会雑誌   Vol. 56   page: 20-23   2005

  41. G群溶連菌感染症(GGS)により早期新生児死亡をきたした低出生体重児の1例

    深見達弥、出良弘、窪田孝明、村松和彦

    周産期医学   Vol. 35   page: 1425-1428   2005

  42. Acute pancreatitis occurring in the early postpartum period: a case report.

    Fukami T, Chaen H, Imura H, Sudou K, Eguchi F.:

    Journal of Perinatal Medicine   Vol. 31   page: 345-349   2003

     More details

  43. 高年産婦の陣痛

    瓦林達比古, 大竹良子, 深見達弥, 鳥巣弘道, 浜田一志, 堀内新司, 董培新, 吉里俊幸

    産婦人科の実際   Vol. 52   page: 1439-1443   2003

  44. 分娩時産褥期の救急症候,乏尿・無尿

    深見達弥,牧野康男,瓦林達比古

    臨床婦人科産科   Vol. 57   page: 310-313   2003

     More details

  45. 緊急帝王切開前に一時的下大静脈フィルターを挿入した深部静脈血栓症の1例

    深見達弥, 窪田孝明, 谷口洋三, 長野一郎, 山田明, 田中康司, 荘田恭仁

    福岡大学医学紀要   Vol. 29   page: 53-59   2002

  46. 福岡大学産婦人科におけるクリニカルパスの有用性について

    深見達弥, 辻岡寛, 宮川孝, 浅井美由紀, 麻生民子, 瓦林達比古

    福岡大学医学紀要   Vol. 29   page: 231-236   2002

  47. 大量の腹水貯留を来たした重症妊娠中毒症の1例

    佐々木舞, 牧野康雄, 宮原大輔, 牧野郁子, 深見達弥, 金岡毅, 瓦林達比古

    福岡大学医学紀要   Vol. 28   page: 123-126   2001

▼display all